Founded in 2018, Aknamed operates in Enterprise Tech industry. Initially focused on streamlining medication management systems, the company has evolved to provide comprehensive solutions for pharmacie...
Funding stage:
Undisclosed
Last funding:
17/09/2021
Total funding:
$56.67 Mn+
Revenue:
Investors
Employee count:
194
Last 90d
194
Last 90d
Web traffic:
2.48K
2.48K
Last 30d
Last 30d
Glassdoor Rating:
Aknamed: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders6
Latest Filing Date30 March 2022- Funding Events19
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Aknamed
As of 31 March 2022, Aknamed's equity is held by 6 shareholders, with the top three being PharmEasy, Lightstone Fund SA, and Akriva.
PharmEasy holds the largest stake in Aknamed at 67.3% as of 31 March 2022.
As of 31 March 2022, investors collectively hold 31.8% equity in Aknamed.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links